HM-018

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHM-018
Drug Alias NameHM-018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitors
TargetsJanus kinase
Therapy Area/IndicationsMyeloproliferative DisordersMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHutchison Medipharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHutchison Medipharma Ltd
Active IndicationsN/A
Inactive IndicationsMyeloproliferative DisordersMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A